The Safety of Tricyclic Antidepressants and Mood Stabilizers in Pregnancy: What Should We Use for The Treatment of Bipolar Disorders?

被引：0
|
作者：
Ornoy, Asher [1 ]
机构：
[1] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel
来源：
NEUROTOXICOLOGY AND TERATOLOGY | 2016年 / 55卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
DNTS 22
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [41] Clinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS study (vol 85, 103613, 2023)
    Chen, Chih-Ken
    Yang, Shu-Yu
    Park, Seon-Cheol
    Jang, Ok-Jin
    Zhu, Xiaomin
    Xiang, Yu-Tao
    Ouyang, Wen-Chen
    Javed, Afzal
    Khan, M. Nasar Sayeed
    Grover, Sandeep
    Avasthim, Ajit
    Kallivayalil, Roy Abraham
    Chee, Kok Yoon
    Chemi, Norliza
    Kato, Takahiro A.
    Hayakawa, Kohei
    Pariwatcharakul, Pornjira
    Maramis, Margarita
    Seneviratnet, Lakmi
    Sim, Kang
    Lin, Shih-Ku
    ASIAN JOURNAL OF PSYCHIATRY, 2023, 89
  • [42] Substance use disorders and attention deficit hyperactivity disorder - what should we treat first?
    Torpan, R.
    Stahlfors, F.
    Moica, S.
    Moica, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S473 - S474
  • [43] Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?
    Giovanni Di Minno
    David Navarro
    Carlo Federico Perno
    Mariana Canaro
    Lutz Gürtler
    James W. Ironside
    Hermann Eichler
    Andreas Tiede
    Annals of Hematology, 2017, 96 : 1253 - 1270
  • [44] Risk of adverse pregnancy, delivery and neonatal outcomes associated with bipolar disorder and prenatal use of mood stabilizers: A population-based cohort study
    Chan, Joe Kwun Nam
    Hung, Samson Chun
    Lee, Krystal Chi Kei
    Cheung, Ka Wang
    Seto, Mimi Tin-Yan
    Wong, Corine Sau Man
    Lin, Jessie
    Chang, Wing Chung
    PSYCHIATRY RESEARCH, 2024, 339
  • [45] Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?
    Di Minno, Giovanni
    Navarro, David
    Perno, Carlo Federico
    Canaro, Mariana
    Guertler, Lutz
    Ironside, James W.
    Eichler, Hermann
    Tiede, Andreas
    ANNALS OF HEMATOLOGY, 2017, 96 (08) : 1253 - 1270
  • [46] Long-term treatment of bipolar disorder: how should we use lithium salts?
    Del Grande, Claudia
    Muti, Matteo
    Musetti, Laura
    Pergentini, Irene
    Corsi, Martina
    Turri, Milo
    Soldani, Ilaria
    Corsini, Giovanni Umberto
    Dell'Osso, Liliana
    RIVISTA DI PSICHIATRIA, 2012, 47 (06) : 515 - 526
  • [47] What Treatment Should We Use If Drugs Fail for OAB; and, What Really Works After Drugs?
    Bosch, J. L. H. R.
    Kelleher, C.
    van Kerrebroeck, P. E. V.
    Schurch, B.
    NEUROUROLOGY AND URODYNAMICS, 2010, 29 (04) : 658 - 661
  • [48] The safety compared between mood stabilizers monotherapy and combined atypical antipsychotics for bipolar disorder maintenance treatment: An analysis of real world laboratory data
    Li, Xiaohong
    Guo, Tong
    Zhang, Xinwei
    Wang, Gang
    BIPOLAR DISORDERS, 2021, 23 : 56 - 56
  • [49] Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?
    Alastair Macfarlane
    Trisha Greenhalgh
    BMC Pregnancy and Childbirth, 18
  • [50] Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?
    Macfarlane, Alastair
    Greenhalgh, Trisha
    BMC PREGNANCY AND CHILDBIRTH, 2018, 18
12345